{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:51:30Z","timestamp":1785711090768,"version":"3.56.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.nano.2026.102948","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:30:31Z","timestamp":1776871831000},"page":"102948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and evaluation of choline tagged mesoporous silica nanoparticles for targeted delivery and imaging in prostate cancer"],"prefix":"10.1016","volume":"74","author":[{"given":"Nikhil","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritha","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Daksh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai Deo","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4981-178X","authenticated-orcid":false,"given":"Anupama","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.nano.2026.102948_bb0005","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00259-017-3700-x","article-title":"PET and PET\/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies","volume":"44","author":"Giovacchini","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.nano.2026.102948_bb0010","doi-asserted-by":"crossref","DOI":"10.2310\/7290.2006.00032","article-title":"Choline transporter as a novel target for molecular imaging of Cancer","volume":"5","author":"Hara","year":"2006","journal-title":"Mol Imaging"},{"issue":"15","key":"10.1016\/j.nano.2026.102948_bb0015","doi-asserted-by":"crossref","first-page":"12509","DOI":"10.1021\/acsomega.1c04256","article-title":"[(99m)Tc]Tc-DTPA-Bis(cholineethylamine) as an oncologic tracer for the detection of choline transporter (ChT) and choline kinase (ChK) expression in Cancer","volume":"7","author":"Jaswal","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.nano.2026.102948_bb0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cytogfr.2016.10.002","article-title":"Molecular structure and differential function of choline kinases CHKalpha and CHKbeta in musculoskeletal system and cancer","volume":"33","author":"Chen","year":"2017","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.nano.2026.102948_bb0025","first-page":"60","article-title":"Docetaxel: An update on its molecular mechanisms, therapeutic trajectory and nanotechnology in the treatment of breast, lung and prostate cancer","author":"Imran","year":"2020","journal-title":"J Drug Delivery Sci Technol"},{"key":"10.1016\/j.nano.2026.102948_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114392","article-title":"Paclitaxel and docetaxel resistance in prostate cancer: molecular mechanisms and possible therapeutic strategies","volume":"160","author":"Hashemi","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.nano.2026.102948_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40139-021-00223-3","article-title":"A reflection on the mechanism of the role of nanoparticles in increasing the efficacy of anti-tumour properties of docetaxel","volume":"9","author":"Manivannan","year":"2021","journal-title":"Curr Pathobiol Rep"},{"key":"10.1016\/j.nano.2026.102948_bb0040","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.2147\/OTT.S113815","article-title":"Mesoporous silica nanoparticles functionalized with folic acid\/methionine for active targeted delivery of docetaxel","volume":"9","author":"Khosravian","year":"2016","journal-title":"Onco Targets Ther"},{"issue":"4","key":"10.1016\/j.nano.2026.102948_bb0045","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1021\/mp100119f","article-title":"HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release","volume":"7","author":"Etrych","year":"2010","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.nano.2026.102948_bb0050","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1021\/acsomega.8b02909","article-title":"PSMA-targeted mesoporous silica nanoparticles for selective intracellular delivery of docetaxel in prostate Cancer cells","volume":"4","author":"Rivero-Buceta","year":"2019","journal-title":"ACS Omega"},{"issue":"10","key":"10.1016\/j.nano.2026.102948_bb0055","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","article-title":"Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing Cancer?","volume":"27","author":"Nakamura","year":"2016","journal-title":"Bioconjug Chem"},{"issue":"47","key":"10.1016\/j.nano.2026.102948_bb0060","doi-asserted-by":"crossref","first-page":"19573","DOI":"10.1039\/C6NR07062K","article-title":"(99m)Tc-conjugated manganese-based mesoporous silica nanoparticles for SPECT, pH-responsive MRI and anti-cancer drug delivery","volume":"8","author":"Gao","year":"2016","journal-title":"Nanoscale"},{"issue":"31","key":"10.1016\/j.nano.2026.102948_bb0065","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1021\/acsami.6b04827","article-title":"(99m)Tc-labeled multifunctional low-generation dendrimer-entrapped gold nanoparticles for targeted SPECT\/CT dual-mode imaging of tumors","volume":"8","author":"Li","year":"2016","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2026.102948_bb0070","first-page":"64","article-title":"Current strategies of radiopharmaceuticals in theranostic applications","author":"Shende","year":"2021","journal-title":"J Drug Delivery Sci Technol"},{"key":"10.1016\/j.nano.2026.102948_bb0075","first-page":"20 (29)","article-title":"Tri-functionalization of mesoporous silica nanoparticles for comprehensive cancer theranostics\u2014the trio of imaging, targeting and therapy","author":"Cheng","year":"2010","journal-title":"J Mater Chem"},{"issue":"5","key":"10.1016\/j.nano.2026.102948_bb0080","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1039\/C4TB01583E","article-title":"A targeted, image-guided and dually locked photoresponsive drug delivery system","volume":"3","author":"Karthik","year":"2015","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.nano.2026.102948_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117125","article-title":"PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer","volume":"177","author":"Adekiya","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"10.1016\/j.nano.2026.102948_bb0090","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1158\/1078-0432.CCR-21-4531","article-title":"Prostate-specific membrane antigen expression and response to DNA damaging agents in prostate Cancer","volume":"28","author":"Sheehan","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nano.2026.102948_bb0095","doi-asserted-by":"crossref","DOI":"10.1177\/17588359211053898","article-title":"PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?","volume":"13","author":"Giraudet","year":"2021","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"10.1016\/j.nano.2026.102948_bb0100","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.clgc.2023.12.008","article-title":"Oral toxicities of PSMA-targeted immunotherapies for the Management of Prostate Cancer","volume":"22","author":"Emperumal","year":"2024","journal-title":"Clin Genitourin Cancer"},{"issue":"20","key":"10.1016\/j.nano.2026.102948_bb0105","doi-asserted-by":"crossref","first-page":"10022","DOI":"10.1021\/acs.iecr.5c00287","article-title":"Uranium sequestration with bisphosphonate-grafted mesoporous silica: sorption behavior, mechanistic insights, and in vitro evaluation","volume":"64","author":"Kumar","year":"2025","journal-title":"Ind Eng Chem Res"},{"issue":"20","key":"10.1016\/j.nano.2026.102948_bb0110","doi-asserted-by":"crossref","first-page":"8358","DOI":"10.1039\/C4AY01786B","article-title":"Magnetic solid-phase extraction of proteins based on hydroxy functional ionic liquid-modified magnetic nanoparticles","volume":"6","author":"Chen","year":"2014","journal-title":"Anal Methods"},{"issue":"24","key":"10.1016\/j.nano.2026.102948_bb0115","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1039\/D1DT00605C","article-title":"Mesoporous silica nanoparticles with manganese and lanthanide salts: synthesis, characterization and cytotoxicity studies","volume":"50","author":"Forte","year":"2021","journal-title":"Dalton Trans"},{"issue":"5","key":"10.1016\/j.nano.2026.102948_bb0120","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1039\/C4TB01423E","article-title":"Metal chelate grafting at the surface of mesoporous silica nanoparticles (MSNs): physico-chemical and biomedical imaging assessment","volume":"3","author":"Laprise-Pelletier","year":"2015","journal-title":"J Mater Chem B"},{"issue":"1","key":"10.1016\/j.nano.2026.102948_bb0125","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1038\/s41598-020-80529-1","article-title":"An effective strategy for development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer","volume":"11","author":"Thambiraj","year":"2021","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.nano.2026.102948_bb0130","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1039\/D1NJ06135F","article-title":"Fabrication of tailored rod-shaped carbon nitride, g-C3N4, decorated with MoSe2 flowers for the catalytic reduction of nitrophenol, organic dye degradation and biocompatibility studies","volume":"46","author":"Sarma","year":"2022","journal-title":"New J Chem"},{"issue":"5","key":"10.1016\/j.nano.2026.102948_bb0135","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/10717540802006500","article-title":"Etoposide loaded PLGA and PCL nanoparticles II: biodistribution and pharmacokinetics after radiolabeling with Tc-99m","volume":"15","author":"Snehalatha","year":"2008","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2026.102948_bb0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.msec.2015.06.030","article-title":"Synthesis, characterization, and biodistribution studies of (99m)Tc-labeled SBA-16 mesoporous silica nanoparticles","volume":"56","author":"de Barros","year":"2015","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.nano.2026.102948_bb0145","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.micromeso.2016.10.041","article-title":"Mesoporous silica as multiple nanoparticles systems for inflammation imaging as nano-radiopharmaceuticals","volume":"239","author":"Pascual","year":"2017","journal-title":"Microporous Mesoporous Mater"},{"issue":"sup1","key":"10.1016\/j.nano.2026.102948_bb0150","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1080\/21691401.2018.1443941","article-title":"Magnetic core mesoporous silica nanoparticles doped with dacarbazine and labelled with 99mTc for early and differential detection of metastatic melanoma by single photon emission computed tomography","volume":"46","author":"Portilho","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1016\/j.nano.2026.102948_bb0155","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.2147\/DDDT.S366622","article-title":"Prostate Cancer therapy using docetaxel and Formononetin combination: hyaluronic acid and epidermal growth factor receptor targeted peptide dual ligands modified binary nanoparticles to facilitate the in vivo anti-tumor activity","volume":"16","author":"Dong","year":"2022","journal-title":"Drug Des Devel Ther"},{"issue":"18","key":"10.1016\/j.nano.2026.102948_bb0160","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1039\/D2NR00783E","article-title":"Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells","volume":"14","author":"Tiburcius","year":"2022","journal-title":"Nanoscale"},{"issue":"44","key":"10.1016\/j.nano.2026.102948_bb0165","doi-asserted-by":"crossref","first-page":"25318","DOI":"10.1039\/C9RA04513A","article-title":"Novel vinyl-modified RGD conjugated silica nanoparticles based on photo click chemistry for in vivo prostate cancer targeted fluorescence imaging","volume":"9","author":"Li","year":"2019","journal-title":"RSC Adv"},{"issue":"sup3","key":"10.1016\/j.nano.2026.102948_bb0170","doi-asserted-by":"crossref","first-page":"S1115","DOI":"10.1080\/21691401.2018.1533843","article-title":"Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution","volume":"46","author":"Saroj","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"38","key":"10.1016\/j.nano.2026.102948_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202203325","article-title":"A supramolecular self-assembling Nanoagent by inducing intracellular aggregation of PSMA for prostate Cancer molecularly targeted Theranostics","volume":"18","author":"Zhang","year":"2022","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.nano.2026.102948_bb0180","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1038\/s41598-024-55600-w","article-title":"High biocompatible FITC-conjugated silica nanoparticles for cell labeling in both in vitro and in vivo models","volume":"14","author":"Nguyen","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.nano.2026.102948_bb0185","doi-asserted-by":"crossref","first-page":"11506","DOI":"10.1038\/s41598-019-47743-y","article-title":"Nanoencapsulated betulinic acid analogue distinctively improves colorectal carcinoma in vitro and in vivo","volume":"9","author":"Dutta","year":"2019","journal-title":"Sci Rep"},{"issue":"53","key":"10.1016\/j.nano.2026.102948_bb0190","doi-asserted-by":"crossref","first-page":"31961","DOI":"10.1039\/D0RA05793B","article-title":"Quercetin loaded folate targeted plasmonic silver nanoparticles for light activated chemo-photothermal therapy of DMBA induced breast cancer in Sprague Dawley rats","volume":"10","author":"Bose","year":"2020","journal-title":"RSC Adv"},{"key":"10.1016\/j.nano.2026.102948_bb0195","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.2147\/IJN.S184634","article-title":"Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells","volume":"13","author":"Tambe","year":"2018","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"10.1016\/j.nano.2026.102948_bb0200","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1021\/acs.bioconjchem.6b00024","article-title":"Bivalent approach for Homodimeric estradiol based ligand: synthesis and evaluation for targeted Theranosis of ER(+) breast carcinomas","volume":"27","author":"Chauhan","year":"2016","journal-title":"Bioconjug Chem"},{"issue":"12","key":"10.1016\/j.nano.2026.102948_bb0205","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1021\/acs.molpharmaceut.7b00529","article-title":"In vitro dissolution, cellular membrane permeability, and anti-inflammatory response of resveratrol-encapsulated mesoporous silica nanoparticles","volume":"14","author":"Juere","year":"2017","journal-title":"Mol Pharm"},{"issue":"20","key":"10.1016\/j.nano.2026.102948_bb0210","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1021\/ja042601m","article-title":"MCM-48-like large mesoporous silicas with tailored pore structure: facile synthesis domain in a ternary triblock copolymer-butanol-water system","volume":"127","author":"Kim","year":"2005","journal-title":"J Am Chem Soc"},{"issue":"2","key":"10.1016\/j.nano.2026.102948_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020218","article-title":"Boosting antimicrobial activity of ciprofloxacin by functionalization of mesoporous silica nanoparticles","volume":"13","author":"de Juan Mora","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.nano.2026.102948_bb0220","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/slct.201600406","article-title":"Co-templating synthesis of bimodal mesoporous silica for potential drug carrier","volume":"1","author":"Chu","year":"2016","journal-title":"ChemistrySelect"},{"issue":"14","key":"10.1016\/j.nano.2026.102948_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26144247","article-title":"High surface area mesoporous silica nanoparticles with tunable size in the sub-micrometer regime: insights on the size and porosity control mechanisms","volume":"26","author":"Rizzi","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.nano.2026.102948_bb0230","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jscs.2020.01.003","article-title":"Functionalized mesoporous silica nanoparticles templated by pyridinium ionic liquid for hydrophilic and hydrophobic drug release application","volume":"24","author":"Zaharudin","year":"2020","journal-title":"J Saudi Chem Soc"},{"issue":"20","key":"10.1016\/j.nano.2026.102948_bb0235","doi-asserted-by":"crossref","first-page":"11745","DOI":"10.1021\/acsomega.0c01078","article-title":"Insight into the loading and release properties of MCM-48\/biopolymer composites as carriers for 5-fluorouracil: equilibrium modeling and pharmacokinetic studies","volume":"5","author":"Abukhadra","year":"2020","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.nano.2026.102948_bb0240","doi-asserted-by":"crossref","first-page":"9837","DOI":"10.1038\/s41598-023-37090-4","article-title":"Applying MCM-48 mesoporous material, equilibrium, isotherm, and mechanism for the effective adsorption of 4-nitroaniline from wastewater","volume":"13","author":"Ali","year":"2023","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.nano.2026.102948_bb0245","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s42250-022-00482-6","article-title":"Real heavy crude oil desulfurization onto nanoporous activated carbon implementing batch adsorption process: equilibrium, kinetics, and thermodynamic studies","volume":"6","author":"Al-Khodor","year":"2022","journal-title":"Chem Afr"},{"issue":"12","key":"10.1016\/j.nano.2026.102948_bb0250","doi-asserted-by":"crossref","first-page":"9788","DOI":"10.1021\/nn2033105","article-title":"Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles","volume":"5","author":"Gao","year":"2011","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.nano.2026.102948_bb0255","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1039\/C4NR06114D","article-title":"Large pore mesoporous silica nanomaterials for application in delivery of biomolecules","volume":"7","author":"Knezevic","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/j.nano.2026.102948_bb0260","first-page":"999","article-title":"Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells","volume":"7","author":"Liu","year":"2012","journal-title":"Int J Nanomedicine"},{"issue":"16","key":"10.1016\/j.nano.2026.102948_bb0265","doi-asserted-by":"crossref","DOI":"10.1039\/c0jm03851b","article-title":"Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility","volume":"21","author":"He","year":"2011","journal-title":"J Mater Chem"},{"issue":"31","key":"10.1016\/j.nano.2026.102948_bb0270","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1016\/j.biomaterials.2013.06.042","article-title":"The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel","volume":"34","author":"Wang","year":"2013","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.nano.2026.102948_bb0275","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1021\/acs.biomac.5b00589","article-title":"Noncovalent surface locking of mesoporous silica nanoparticles for exceptionally high hydrophobic drug loading and enhanced colloidal stability","volume":"16","author":"Palanikumar","year":"2015","journal-title":"Biomacromolecules"},{"issue":"17","key":"10.1016\/j.nano.2026.102948_bb0280","doi-asserted-by":"crossref","first-page":"21722","DOI":"10.1021\/acsami.4c04289","article-title":"Overcoming the blood-brain tumor barrier with docetaxel-loaded mesoporous silica nanoparticles for treatment of Temozolomide-resistant glioblastoma","volume":"16","author":"Hsu","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"10.1016\/j.nano.2026.102948_bb0285","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1089\/adt.2020.1039","article-title":"Albumin-coated mesoporous silica nanoparticles of docetaxel: preparation, characterization, and pharmacokinetic evaluation","volume":"19","author":"Pandita","year":"2021","journal-title":"Assay Drug Dev Technol"},{"issue":"1","key":"10.1016\/j.nano.2026.102948_bb0290","doi-asserted-by":"crossref","first-page":"20661","DOI":"10.1038\/s41598-022-25095-4","article-title":"Organically surface engineered mesoporous silica nanoparticles control the release of quercetin by pH stimuli","volume":"12","author":"Saputra","year":"2022","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.nano.2026.102948_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/nano11051293","article-title":"A comprehensive study of drug loading in hollow mesoporous silica nanoparticles: impacting factors and loading efficiency","volume":"11","author":"Guo","year":"2021","journal-title":"Nanomaterials (Basel)"},{"issue":"10","key":"10.1016\/j.nano.2026.102948_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/biom12101522","article-title":"Methods for Radiolabelling nanoparticles: SPECT use (part 1)","volume":"12","author":"Varani","year":"2022","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.nano.2026.102948_bb0305","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft excel","volume":"99","author":"Zhang","year":"2010","journal-title":"Comput Methods Prog Biomed"},{"issue":"5","key":"10.1016\/j.nano.2026.102948_bb0310","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/1061186X.2012.761222","article-title":"Aptamer-based nanoparticles for cancer targeting","volume":"21","author":"Sa","year":"2013","journal-title":"J Drug Target"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:24:49Z","timestamp":1785709489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426000493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":62,"alternative-id":["S1549963426000493"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.102948","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and evaluation of choline tagged mesoporous silica nanoparticles for targeted delivery and imaging in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.102948","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102948"}}